If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSage Group Regulatory News (SGE)

Share Price Information for Sage Group (SGE)

Share Price is delayed by 15 minutes
Get Live Data
839.00    0.00 (0.00%)
Bid:
0.00
Ask:
890.00
Spread: 49.00 (5.826%)
Market Cap: £7.53b
SGE Live PriceLast checked at - London Stock Exchange

Intraday Sage Group Share Chart

Trading Update

17 Jan 2019 07:00

RNS Number : 3189N
Sage Group PLC
17 January 2019
 

Trading update for the three months ended 31 December 2018

The Sage Group plc (the Group) is today issuing its trading update for the three months ended 31 December 2018.

Financial performance

Group organic1 revenue increased by 7.6% to £465m for the first three months of the year.

Recurring revenue increased by 10.5% to £387m, underpinned by software subscription growth of 27.7% to £237m, building on the momentum generated at the end of FY18 as the business continues to focus on subscription, assisted by a softer comparator in Q1 18. Software and software related services (SSRS) revenue declined by 5.8% to £65m reflecting the managed decline in licences as the business transitions to subscription, offset by a slight increase in services.

Organic revenue growth of 7.6% reflects growth in products within, or to be migrated to, Sage Business Cloud of 9.3% to £380m and a slight increase of 0.6% to £85m in products with no current path to Sage Business Cloud. 

Regionally, North America delivered revenue growth of 10.4% to £154m, with double digit recurring revenue driven by cloud connected solutions and Sage Intacct. The UKI showed strong signs of recovery with revenue growth of 5.9% to £96m and double digit recurring revenue growth driven by Sage 50 cloud connected migrations. In France, revenue growth of 5.8% to £69m reflects continuing recovery in recurring revenue, driven by Sage 200 cloud connected. Performance in other regions was largely in line with expectations.

Sage announced on 15 January 2019 that it has entered into an agreement for the sale of Sage Payroll Solutions to iSolved HCM, LLC. This business was classified as held for sale and excluded from organic numbers at year end FY18. 

Steve Hare, Chief Executive Officer, commented:

"We have been encouraged by the strong start to FY19, reflecting the renewed focus on high-quality subscription and recurring revenue as we continue the journey to becoming a great SaaS business. Looking ahead we reiterate our full year guidance for FY19 as outlined at the FY18 results announcement."

Foreign exchange

Sterling has weakened against the US Dollar and the Euro, leading to exchange rate tailwinds, particularly in the translation of the US Dollar. 

Financial position

The Group's financial position remains strong and net debt as at 31 December 2018 was £602m (£668m as at 30 September 2018). 

 Analyst and investor conference call

Steve Hare, CEO and Jonathan Howell, CFO will be hosting a conference call at 08:30am GMT today. The call can be accessed using the dial-in number 0800 279 6619 (United Kingdom) or +44 (0) 2071 928 338 (International) and pin code 8799633. A replay of the call will also be available for one week after the event: dial in number 0871 700 0471 (United Kingdom) or +44 (0) 3333 009 785 (International), pin code 8799633.

 

 

Enquiries

The Sage Group plc

+44(0) 191 294 3457

Jonathan Howell, Chief Financial Officer

Lauren Wholley, Investor Relations

Amy Lawson, Media

 

FTI Consulting +44(0) 20 3727 1000

Charles Palmer

Dwight Burden

 

About Sage

Sage is the global market leader for technology that helps businesses of all sizes manage everything from money to people - whether they're a start-up, scale-up or enterprise. We do this through Sage Business Cloud - the one and only business management solution that customers will ever need, comprising Accounting, Financials, Sage Intacct, Enterprise Management, People & Payroll and Payments & Banking.

 

1 All numbers throughout this document are organic unless otherwise stated.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTGGUACGUPBPUQ
Date   Source Headline
31st Dec 20241:25 pmRNSTotal Voting Rights
30th Dec 20245:49 pmRNSTransaction in Own Shares
27th Dec 20245:45 pmRNSTransaction in Own Shares
27th Dec 20247:00 amRNSTransaction in Own Shares
23rd Dec 20245:30 pmRNSTransaction in Own Shares
20th Dec 20245:25 pmRNSTransaction in Own Shares
19th Dec 20246:03 pmRNSDirector/PDMR Shareholding
19th Dec 20245:26 pmRNSTransaction in Own Shares
18th Dec 20245:29 pmRNSTransaction in Own Shares
17th Dec 20246:00 pmRNSTransaction in Own Shares
17th Dec 20244:30 pmRNSDirector/PDMR Shareholding
16th Dec 20249:30 amRNSDirectorate Change
10th Dec 20245:46 pmRNSTransaction in Own Shares
9th Dec 20241:30 pmRNSHolding(s) in Company
6th Dec 20244:30 pmRNSDirector/PDMR Shareholding
6th Dec 202410:45 amRNSBlock listing Interim Review
5th Dec 20246:00 pmRNSDirector/PDMR Shareholding
5th Dec 202411:00 amRNSNotice of AGM
5th Dec 202410:00 amRNSDirector/PDMR Shareholding
5th Dec 202410:00 amRNSDirector/PDMR Shareholding
4th Dec 20245:42 pmRNSTransaction in Own Shares
3rd Dec 20244:30 pmRNSDirector/PDMR Shareholding
3rd Dec 202410:45 amRNSAnnual Financial Report
2nd Dec 20245:45 pmRNSTransaction in Own Shares
29th Nov 20245:50 pmRNSTransaction in Own Shares
29th Nov 20245:50 pmRNSTotal Voting Rights
28th Nov 20245:30 pmRNSTransaction in Own Shares
28th Nov 20242:00 pmRNSDirector/PDMR Shareholding
27th Nov 20245:39 pmRNSTransaction in Own Shares
26th Nov 20245:30 pmRNSTransaction in Own Shares
25th Nov 20246:25 pmRNSDirector/PDMR Shareholding
25th Nov 20246:00 pmRNSTransaction in Own Shares
22nd Nov 20246:14 pmRNSTransaction in Own Shares
22nd Nov 20249:30 amRNSDirector/PDMR Shareholding
21st Nov 20245:39 pmRNSTransaction in Own Shares
20th Nov 20245:51 pmRNSTransaction in Own Shares
20th Nov 20247:00 amRNSResults for the year ended 30 September 2024
20th Nov 20247:00 amRNSSHARE BUYBACK PROGRAMME
31st Oct 20244:00 pmRNSTotal Voting Rights
9th Oct 20243:30 pmRNSHolding(s) in Company
3rd Oct 20242:00 pmRNSDirectorate Change
2nd Oct 202411:11 amRNSDirector/PDMR Shareholding
1st Oct 20245:19 pmRNSTotal Voting Rights
11th Sep 20245:15 pmRNSHolding(s) in Company
11th Sep 20243:30 pmRNSHolding(s) in Company
6th Sep 20243:00 pmRNSDirector Declaration
6th Sep 20243:00 pmRNSHolding(s) in Company
2nd Sep 20245:50 pmRNSTotal Voting Rights
21st Aug 20245:50 pmRNSDirector/PDMR Shareholding
16th Aug 20244:50 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.